inFoods IBS^® is Revolutionary

 

inFoods® IBS helps to identify foods that trigger IBS symptoms

70-80% of irritable bowel syndrome (IBS) patients say food exacerbates or triggers their symptoms - but most patients cannot identify their offending foods.

inFoods® IBS is a laboratory developed test (LDT) designed for the identification of foods that cause an elevated immune response in IBS patients (food-specific IgG antibodies) that may cause or trigger symptoms such as pain and bloating.

Trigger foods and specific cut-off levels were selected for each food in the inFoods IBS panel by comparing the immune responses in healthy control subjects to IBS patients. (A cut-off level is the value used to determine if someone is positive or negative for the food.)

inFoods® IBS was clinically studied at the nation’s leading medical centers (Mayo Clinic, Harvard, University of Michigan, University of Texas Medical Center) with actual IBS Patients. When IBS patients in the study stopped eating foods identified by inFoods® IBS, the majority experienced significant improvement in their IBS symptoms including pain, bloating and bowel movement urgency.

 

Why is inFoods^® IBS revolutionary?

• inFoods® IBS utilizes a patented & clinically proven approach to detect IgG antibodies to IBS-specific foods
• The inFoods® IBS panel and the clinically determined cut-offs for each food are specific to IBS patients
• inFoods® IBS helps to improve IBS patient´s quality of life by reducing pain, bloating and other food-triggered symptoms of IBS
• inFoods® IBS reduces patient frustration and shortens time to relief when compared to complex non-specific food elimination diets
• inFoods® IBS can improve health outcomes and reduce costs by identifying IBS trigger foods before symptoms occur

 

inFoods® IBS is a laboratory developed test (LDT) powered by Ethos Laboratories , a CLIA and CAP-accredited high-complexity lab. inFoods® IBS has not been approved or cleared by the FDA.